Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Product type
Topic
- Legislation (77)
- Advertising (25)
- Manufacturing (19)
- Labelling and packaging (16)
- Vaping hub (13)
- COVID-19 (11)
- Compliance and enforcement (6)
- Scheduling (national classification system) (6)
- Import and export (2)
- Clinical trials (1)
- Committees and advisory bodies (1)
- Medicinal cannabis hub (1)
- Sunscreens (1)
- Urogynaecological (transvaginal) surgical mesh hub (1)
Search
6 result(s) found, displaying 1 to 6
-
Regulatory decision noticesVoluntary cancellation of AstraZeneca COVID-19 vaccine: Vaxzevria
-
Regulatory decision noticesWe've granted a labelling exemption for the COVID-19 Vaccine, Pfizer (raxtozinameran), under the current Poisons Standard.
-
Regulatory decision noticesThis instrument is made under section 39 of the current Poisons Standard.
-
Regulatory decision noticesThe TGA has provisionally approved Moderna's bivalent COVID-19 vaccine, elasomeran/imelasomeran (SPIKEVAX Bivalent Original/Omicron) for use as a booster dose in adults 18 years and over.
-
Regulatory decision noticesThe TGA has granted provisional approval to Biocelect Pty Ltd (on behalf of Novavax Inc) for its COVID-19 vaccine, NUVAXOVID.
-
Regulatory decision noticesThe TGA has provisionally approved the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for use as a booster in individuals aged 12 to 15 years old.